Medical Care Technologies, Inc. Rolls Out Teledermatology Application

BEIJING -- (Marketwire) -- 02/09/10 -- Medical Care Technologies Inc. (OTCBB: MDCE) today announced that as part of the wellness focus of Medical Care Technologies, the company is rolling out a Teledermatology application. Teledermatology is described as the practice of dermatology using available communication and information technology. Teledermatology is an important area of telemedicine activity that focuses primarily on the diagnosis and treatment of dermatologic conditions.



Medical Care Technologies Teledermatology incorporates both Store and Forward Teledermatology as well as live video teleconference Teledermatology. Live Video conferencing Teledermatology uses video and audio transmission for interactive consultation. Store and Forward Teledermatology incorporates clinical images and clinical information saved on MCT's Telehealth Suite™ and Medsuite™. In fact, the unique aspect of mobile Teledermatology is that this system might become a filtering or triage system allowing a more sensible approach for the management of patients with emergent skin diseases. In addition, mobile Teledermatology may also become a powerful screening tool for malignant cutaneous tumors.



The world dermatological market generated total sales revenues of over $18bn in 2007. VISIONGAIN predicts "that this market area will increase significantly, based on expansion of the market for modern drugs to treat skin disorders in developing and populated areas, most notably in countries like China and India."



Ning Wu, President of Medical Care Technologies, states, "China is on a path of rapid development. We believe that Chinese dermatology will continue its own parallel rapid progression and that Teledermatology consultation is well suited to our current applications, as well as being a much needed service in China."



About Medical Care Technologies Inc.



Medical Care Technologies Inc. ( www.medicaretech.com : ) is traded under the symbol MDCE on the OTCBB and is based in London, England. The Company is in the process of moving its portfolio of oil resources into medical care technologies. The products/services that the company hopes to acquire are intended to constitute a healthcare delivery and wellness site, dedicated to helping Asian consumers live healthier, more balanced lives. MDCE is planning to provide advanced connectivity, internationally standardized and secure business technology and information systems to assist the Asian health industry -- physicians, pharmacists, medical institutions, and consumers -- in accessing medical resources, health services, education, wellness and pharmaceutical products throughout Asia. MDCE is planning to distribute and provide services at a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Nutraceuticals. Further information on the Company can be found at www.sec.gov : and the company's website at www.medicaretech.com :